Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.
[Pharmaceutical prescription for multiple sclerosis : Evaluation of pharmaceutical consumption at private health insurance.]
NLRP3 Inflammasome and MS/EAE.
Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis.
Future MRI tools in multiple sclerosis.
Functional brain imaging: an evidence-based analysis.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
Seizure characteristics in multiple sclerosis patients.
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Colour vision impairment is associated with disease severity in multiple sclerosis.
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
Head Tracking Latency in Virtual Environments Revisited: Do Users with Multiple Sclerosis Notice Latency Less?
Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Pages
« first
‹ previous
…
388
389
390
391
392
393
394
395
396
…
next ›
last »